144 related articles for article (PubMed ID: 28803992)
21. Silencing FYVE, RhoGEF, and PH domain containing 1 (FGD1) suppresses melanoma progression by inhibiting PI3K/AKT signaling pathway.
Niu Z; Li Y; Xu Y; Jiang W; Tao R; Chen Y; Han Y
Bioengineered; 2021 Dec; 12(2):12193-12205. PubMed ID: 34783295
[TBL] [Abstract][Full Text] [Related]
22. Involvement of a Rac activator,P-Rex1, in neurotrophin-derived signaling and neuronal migration.
Yoshizawa M; Kawauchi T; Sone M; Nishimura YV; Terao M; Chihama K; Nabeshima Y; Hoshino M
J Neurosci; 2005 Apr; 25(17):4406-19. PubMed ID: 15858067
[TBL] [Abstract][Full Text] [Related]
23. P-Rex1 Controls Sphingosine 1-Phosphate Receptor Signalling, Morphology, and Cell-Cycle Progression in Neuronal Cells.
Hampson E; Tsonou E; Baker MJ; Hornigold DC; Hubbard RE; Massey A; Welch HCE
Cells; 2021 Sep; 10(9):. PubMed ID: 34572121
[TBL] [Abstract][Full Text] [Related]
24. P-Rex1 participates in Neuregulin-ErbB signal transduction and its expression correlates with patient outcome in breast cancer.
Montero JC; Seoane S; Ocaña A; Pandiella A
Oncogene; 2011 Mar; 30(9):1059-71. PubMed ID: 21042280
[TBL] [Abstract][Full Text] [Related]
25. Selective activation of Akt1 by mammalian target of rapamycin complex 2 regulates cancer cell migration, invasion, and metastasis.
Kim EK; Yun SJ; Ha JM; Kim YW; Jin IH; Yun J; Shin HK; Song SH; Kim JH; Lee JS; Kim CD; Bae SS
Oncogene; 2011 Jun; 30(26):2954-63. PubMed ID: 21339740
[TBL] [Abstract][Full Text] [Related]
26. Gβγ signaling to the chemotactic effector P-REX1 and mammalian cell migration is directly regulated by Gα
Cervantes-Villagrana RD; Adame-García SR; García-Jiménez I; Color-Aparicio VM; Beltrán-Navarro YM; König GM; Kostenis E; Reyes-Cruz G; Gutkind JS; Vázquez-Prado J
J Biol Chem; 2019 Jan; 294(2):531-546. PubMed ID: 30446620
[TBL] [Abstract][Full Text] [Related]
27. Long noncoding RNA ZFAS1 promotes tumorigenesis through regulation of miR-150-5p/RAB9A in melanoma.
Liang L; Zhang Z; Qin X; Gao Y; Zhao P; Liu J; Zeng W
Melanoma Res; 2019 Dec; 29(6):569-581. PubMed ID: 30889053
[TBL] [Abstract][Full Text] [Related]
28. PI3K regulates MEK/ERK signaling in breast cancer via the Rac-GEF, P-Rex1.
Ebi H; Costa C; Faber AC; Nishtala M; Kotani H; Juric D; Della Pelle P; Song Y; Yano S; Mino-Kenudson M; Benes CH; Engelman JA
Proc Natl Acad Sci U S A; 2013 Dec; 110(52):21124-9. PubMed ID: 24327733
[TBL] [Abstract][Full Text] [Related]
29. Phosphorylation of P-Rex1 at serine 1169 participates in IGF-1R signaling in breast cancer cells.
Montero JC; Seoane S; Pandiella A
Cell Signal; 2013 Nov; 25(11):2281-9. PubMed ID: 23899556
[TBL] [Abstract][Full Text] [Related]
30. Protein Kinase A (PKA) Type I Interacts with P-Rex1, a Rac Guanine Nucleotide Exchange Factor: EFFECT ON PKA LOCALIZATION AND P-Rex1 SIGNALING.
Chávez-Vargas L; Adame-García SR; Cervantes-Villagrana RD; Castillo-Kauil A; Bruystens JG; Fukuhara S; Taylor SS; Mochizuki N; Reyes-Cruz G; Vázquez-Prado J
J Biol Chem; 2016 Mar; 291(12):6182-99. PubMed ID: 26797121
[TBL] [Abstract][Full Text] [Related]
31. Phosphorylation of P-Rex1 by the cyclic AMP-dependent protein kinase inhibits the phosphatidylinositiol (3,4,5)-trisphosphate and Gbetagamma-mediated regulation of its activity.
Mayeenuddin LH; Garrison JC
J Biol Chem; 2006 Jan; 281(4):1921-8. PubMed ID: 16301320
[TBL] [Abstract][Full Text] [Related]
32. GLI2-mediated melanoma invasion and metastasis.
Alexaki VI; Javelaud D; Van Kempen LC; Mohammad KS; Dennler S; Luciani F; Hoek KS; Juàrez P; Goydos JS; Fournier PJ; Sibon C; Bertolotto C; Verrecchia F; Saule S; Delmas V; Ballotti R; Larue L; Saiag P; Guise TA; Mauviel A
J Natl Cancer Inst; 2010 Aug; 102(15):1148-59. PubMed ID: 20660365
[TBL] [Abstract][Full Text] [Related]
33. TWIST1 is an ERK1/2 effector that promotes invasion and regulates MMP-1 expression in human melanoma cells.
Weiss MB; Abel EV; Mayberry MM; Basile KJ; Berger AC; Aplin AE
Cancer Res; 2012 Dec; 72(24):6382-92. PubMed ID: 23222305
[TBL] [Abstract][Full Text] [Related]
34. High LIFr expression stimulates melanoma cell migration and is associated with unfavorable prognosis in melanoma.
Guo H; Cheng Y; Martinka M; McElwee K
Oncotarget; 2015 Sep; 6(28):25484-98. PubMed ID: 26329521
[TBL] [Abstract][Full Text] [Related]
35. The Phosphatidylinositol (3,4,5)-Trisphosphate-dependent Rac Exchanger 1·Ras-related C3 Botulinum Toxin Substrate 1 (P-Rex1·Rac1) Complex Reveals the Basis of Rac1 Activation in Breast Cancer Cells.
Lucato CM; Halls ML; Ooms LM; Liu HJ; Mitchell CA; Whisstock JC; Ellisdon AM
J Biol Chem; 2015 Aug; 290(34):20827-20840. PubMed ID: 26112412
[TBL] [Abstract][Full Text] [Related]
36. Overexpression of CDCA8 promotes the malignant progression of cutaneous melanoma and leads to poor prognosis.
Ci C; Tang B; Lyu D; Liu W; Qiang D; Ji X; Qiu X; Chen L; Ding W
Int J Mol Med; 2019 Jan; 43(1):404-412. PubMed ID: 30431060
[TBL] [Abstract][Full Text] [Related]
37. SSRP1 Worsens Malignant Melanoma Progression by Activating MAPKs Pathway.
Yu Y; Gao Y; Yu Y
Ann Clin Lab Sci; 2021 Nov; 51(6):783-789. PubMed ID: 34921031
[TBL] [Abstract][Full Text] [Related]
38. ZNF23 Suppresses Cutaneous Melanoma Cell Malignancy via Mitochondria-Dependent Pathway.
Zhang X; Ding C; Tian H; Dong X; Meng X; Zhu W; Liu B; Wang L; Huang M; Li C
Cell Physiol Biochem; 2017; 43(1):147-157. PubMed ID: 28848158
[TBL] [Abstract][Full Text] [Related]
39. MicroRNA-365 Inhibits Cell Growth and Promotes Apoptosis in Melanoma by Targeting BCL2 and Cyclin D1 (CCND1).
Zhu Y; Wen X; Zhao P
Med Sci Monit; 2018 Jun; 24():3679-3692. PubMed ID: 29858490
[TBL] [Abstract][Full Text] [Related]
40. Overexpressed VEPH1 inhibits epithelial-mesenchymal transition, invasion, and migration of human cutaneous melanoma cells through inactivating the TGF-β signaling pathway.
Feng H; Jia XM; Gao NN; Tang H; Huang W; Ning N
Cell Cycle; 2019 Nov; 18(21):2860-2875. PubMed ID: 31599708
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
